Skip to content

A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.

A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06283732
Enrollment
70
Registered
2024-02-28
Start date
2023-11-15
Completion date
2024-02-15
Last updated
2024-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive System Disease

Keywords

Dietary Supplements, Digestive Health, Well-being, Energy Levels

Brief summary

The study aims to evaluate the effectiveness of a dietary supplement (greens powder), on improving digestive health, quality of life, energy levels, and satiety over a 14-day period. Participants, aged 18-65 and experiencing mild digestive issues, will consume the greens powder daily and report outcomes through diaries and questionnaires.

Interventions

DIETARY_SUPPLEMENTGreens powder

Participants are to consume one scoop (8.5 g) of the greens powder mixed in 8-10 oz of water every morning before breakfast for two weeks.

Sponsors

Citruslabs
CollaboratorINDUSTRY
Amway Corp
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Male or female. * Aged 18-65 years. * Willing to comply with study requirements. * No known allergies to the ingredients listed in the product. * Self-reported mild digestive issues (e.g., occasional bloating, stomach discomfort, occasional constipation, or occasional diarrhea). * Generally healthy - do not live with any uncontrolled chronic disease .

Exclusion criteria

* Pre-existing chronic conditions that would prevent adherence to the protocol, including oncological and psychiatric disorders. * Known severe allergic reactions that require an Epi-Pen. * Women who are pregnant, breastfeeding, or attempting to conceive. * History of severe diagnosed digestive disorders (e.g., IBS, IBD, Crohn's disease) or gastrointestinal-tract surgeries. * Unwillingness to follow the study protocol. * Invasive medical procedure within the last three weeks or planning one during the study period. * History of substance abuse. * Current participation or planning to participate in another research study. * Regular consumption of probiotics, fiber, or prebiotic supplements within 3 weeks of the study. * Regular intake of medications that may interfere with the study or study product (e.g., anticoagulants, laxatives, sedatives, beta-blockers, anti-acids) .

Design outcomes

Primary

MeasureTime frameDescription
Digestive Health Improvement14 days from the start of interventionMeasure the change in digestive health using daily diaries and the Bristol Stool Scale (BSS).

Secondary

MeasureTime frameDescription
Quality of Life and Well-being Enhancement14 days from the start of interventionAssess improvements in participants' quality of life, energy levels, satiety, and overall well-being through validated questionnaires.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026